+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Laryngeal Cancer Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4848115
  • Report
  • September 2019
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Merck and Co. Inc.
  • Sanofi S.A.
  • MORE
The report on the global laryngeal cancer therapeutics market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global laryngeal cancer therapeutics market to grow with a CAGR of 7.1% over the forecast period from 2019-2025. The study on laryngeal cancer therapeutics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on laryngeal cancer therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global laryngeal cancer therapeutics market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global laryngeal cancer therapeutics market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers
  • The rising prevalence of laryngeal cancer
  • The rising number of reimbursement programs
  • The increasing consumption of smoking and alcohol
2) Restraints
  • The availability of alternative treatment options and treatment costs
3) Opportunities
  • The growing research and development promote innovations and create numerous opportunities
Research Methodology

A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global laryngeal cancer therapeutics market is segmented on the basis of product type, and application.

The Global Laryngeal Cancer Therapeutics Market by Product Type
  • Biologics
  • Small Molecules
The Global Laryngeal Cancer Therapeutics Market by Application
  • Hospitals
  • Clinics
  • Other Applications
Company Profiles

The companies covered in the report include
  • Eli Lilly and Company
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche Ltd. and Co.
  • Sanofi S.A.
  • Merck and Co. Inc.
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the laryngeal cancer therapeutics market.
2. Complete coverage of all the segments in the laryngeal cancer therapeutics market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global laryngeal cancer therapeutics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Merck and Co. Inc.
  • Sanofi S.A.
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Laryngeal Cancer Therapeutics Market Highlights
2.2. Laryngeal Cancer Therapeutics Market Projection
2.3. Laryngeal Cancer Therapeutics Market Regional Highlights

3. Global Laryngeal Cancer Therapeutics Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Product Type
3.4.2. Growth Matrix Analysis by Application
3.4.3. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Laryngeal Cancer Therapeutics Market

4. Laryngeal Cancer Therapeutics Market Macro Indicator Analysis

5. Global Laryngeal Cancer Therapeutics Market by Product Type
5.1. Biologics
5.2. Small Molecules

6. Global Laryngeal Cancer Therapeutics Market by Application
6.1. Hospitals
6.2. Clinics
6.3. Other Applications

7. Global Laryngeal Cancer Therapeutics Market by Region 2019-2025
7.1. North America
7.1.1. North America Laryngeal Cancer Therapeutics Market by Product Type
7.1.2. North America Laryngeal Cancer Therapeutics Market by Application
7.1.3. North America Laryngeal Cancer Therapeutics Market by Country
7.2. Europe
7.2.1. Europe Laryngeal Cancer Therapeutics Market by Product Type
7.2.2. Europe Laryngeal Cancer Therapeutics Market by Application
7.2.3. Europe Laryngeal Cancer Therapeutics Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Laryngeal Cancer Therapeutics Market by Product Type
7.3.2. Asia-Pacific Laryngeal Cancer Therapeutics Market by Application
7.3.3. Asia-Pacific Laryngeal Cancer Therapeutics Market by Country
7.4. RoW
7.4.1. RoW Laryngeal Cancer Therapeutics Market by Product Type
7.4.2. RoW Laryngeal Cancer Therapeutics Market by Application
7.4.3. RoW Laryngeal Cancer Therapeutics Market by Sub-region

8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Laryngeal Cancer Therapeutics Market
8.2. Companies Profiled
8.2.1. Eli Lilly and Company
8.2.2. Bristol-Myers Squibb
8.2.3. F. Hoffmann-La Roche Ltd. and Co.
8.2.4. Sanofi S.A.
8.2.5. Merck and Co. Inc.

9. Appendix
9.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Eli Lilly and Company
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche Ltd. and Co.
  • Sanofi S.A.
  • Merck and Co. Inc.
Note: Product cover images may vary from those shown
Adroll
adroll